Endeavor

Researchers Explore New Treatment for Aggressive Head and Neck Cancer

Early clinical trial results suggest dual drug therapy may improve survival for patients with HPV-negative head and neck cancer

New Immunotherapy Strategy Improves Outcomes in Patients with Advanced Head and Neck Cancer

Patients treated with pembrolizumab were at least 27% less likely to experience cancer recurrence or death

Moffitt Experts Answer Common Head and Neck Cancer Questions

April is Head and Neck Cancer Awareness Month

Moffitt Working To Improve Access to Care for Rural Patients

Dennis Davis from Sebring credits Moffitt with saving his life

HPV Vaccine Shows Effectiveness in Reducing Cervical Precancers

CDC report finds widespread vaccination has led to decline in precancerous cervical conditions, particularly among younger women

Moffitt Study Reveals Insights Into Oral HPV Incidence and Risks in Men Across 3 Countries

HPV is linked to up to 90% of male oropharyngeal cancer cases in the United States

Surgeon General Calls for Cancer Warning Labels on Alcohol Products: What You Should Know About Alcohol and Cancer Risk

Learn why the U.S. Surgeon General recommends cancer warning labels on alcohol products and how alcohol consumption can increase cancer risk.

Bolts Fight for a Cure at Hockey Fights Cancer Night

Tampa Bay Lightning game raises $30,000 for cancer research and patient services

A Novel Class of Therapeutic Biologics Shows Promise for HPV-Related Head and Neck Cancer

Combining two treatments may improve outcomes for patients with HPV 16–positive disease